Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...
EntersCO2Transportation and Sequestration Agreement with Vault 44.01 - PEKIN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback